000 | 01518 a2200469 4500 | ||
---|---|---|---|
005 | 20250513071635.0 | ||
264 | 0 | _c19940228 | |
008 | 199402s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00028a010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoufos, I | |
245 | 0 | 0 |
_aSynthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cJan 1994 |
||
300 |
_a268-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetamides _xchemical synthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBatrachotoxins _xmetabolism |
650 | 0 | 4 | _aBenzeneacetamides |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 | _aCell Hypoxia |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPiperidines _xchemistry |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSodium _xmetabolism |
650 | 0 | 4 | _aSodium Channel Blockers |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aVeratridine _xantagonists & inhibitors |
700 | 1 | _aHays, S J | |
700 | 1 | _aDooley, D J | |
700 | 1 | _aSchwarz, R D | |
700 | 1 | _aCampbell, G W | |
700 | 1 | _aProbert, A W | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 37 _gno. 2 _gp. 268-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00028a010 _zAvailable from publisher's website |
999 |
_c8294495 _d8294495 |